CIK: 0001587143
Total reported value
$32.3M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ✓ | Stock-Other | 41.55% | — | — | ||
| 2 | DCPHEUR | Deciphera Pharmaceuticals In | Stock-Other | 19.46% | — | — | |
| 3 | 4XC1 | Kalvista Pharmaceuticals INC | Stock-Other | 16.70% | — | — | |
| 4 | TRXCEUR | Transenterix INC | Stock-Other | 11.26% | — | -12.12% | |
| 5 | STRO | Sutro Biopharma, Inc. | Stock-Other | 8.01% | — | — | |
| 6 | OCUL | Ocular Therapeutix INC | Stock-Other | 1.46% | — | -41.95% | |
| 7 | ✓ | Arsanis INC | Stock-Other | 0.89% | — | — | |
| 8 | ✓ | Catabasis Pharmaceuticals In | Stock-Other | 0.67% | — | — | |
| 9 | ✓ | Enteromedics INC | Stock-Other | — | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | 4XC1 | Kalvista Pharmaceuticals INC | +7.1% | — | Unchanged |
| 2 | ✓ | +5.7% | — | Unchanged | |
| 3 | ✓ | Enteromedics INC | -0.2% | — | Unchanged |
| 4 | ✓ | Catabasis Pharmaceuticals In | -0.6% | — | Unchanged |
| 5 | ✓ | Arsanis INC | -2.2% | — | Unchanged |
| 6 | OCUL | Ocular Therapeutix INC | -2.4% | -41.95% | Trim |
| 7 | TRXCEUR | Transenterix INC | -3.9% | -12.12% | Trim |
| 8 | DCPHEUR | Deciphera Pharmaceuticals In | -11.6% | — | Unchanged |
| 9 | STRO | Sutro Biopharma, Inc. | — | NEW | New buy |